ArticleThe Journal of clinical investigation2018

CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2.

Liying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.